Vanda Pharmaceuticals (VNDA) Deferred Taxes (2010 - 2025)
Vanda Pharmaceuticals recorded quarterly Deferred Taxes of $103.2 million in Q4 2025, up 1827.25% quarter-over-quarter from -$6.0 million in Q3 2025, and up 5491.12% year-over-year from $1.8 million in Q4 2024.
Vanda Pharmaceuticals' Deferred Taxes history runs 8 years deep, the most recent figure standing at $103.2 million for Q4 2025.
- In Q4 2025, Deferred Taxes rose 5491.12% year-over-year to $103.2 million; the TTM figure through Mar 2026 stood at $89.2 million (up 735.93% YoY), while the FY2025 annual figure was $81.4 million, up 1356.45% from the prior year.
- Deferred Taxes came in at $103.2 million for Q4 2025 at Vanda Pharmaceuticals, up from -$6.0 million in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $103.2 million in Q4 2025 to a low of -$8.0 million in Q2 2025.
- A 5-year average of $4.1 million and a median of $85500.0 in 2022 frame the typical range for Deferred Taxes.
- On a YoY basis, Deferred Taxes climbed as much as 5491.12% in 2025 and fell as far as 3069.51% in 2025.
- Vanda Pharmaceuticals' Deferred Taxes stood at $1.3 million in 2021, then tumbled by 68.24% to $417000.0 in 2022, then slumped by 1894.72% to -$7.5 million in 2023, then jumped by 74.43% to -$1.9 million in 2024, then soared by 5491.12% to $103.2 million in 2025.
- According to Business Quant data, Deferred Taxes over the past three periods registered $103.2 million, -$6.0 million, and -$8.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -859,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -65.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 96.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 9.31 Mn |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 103.19 Mn |
| Sep 30, 2025 | -5.97 Mn |
| Jun 30, 2025 | -7.97 Mn |
| Mar 31, 2025 | -7.80 Mn |
| Dec 31, 2024 | -1.91 Mn |
| Sep 30, 2024 | -3.09 Mn |
| Jun 30, 2024 | -1.23 Mn |
| Mar 31, 2024 | -246,000.00 |
| Dec 31, 2023 | -7.48 Mn |
| Sep 30, 2023 | 2.73 Mn |
| Jun 30, 2023 | 1.46 Mn |
| Mar 31, 2023 | 2.01 Mn |
| Dec 31, 2022 | 417,000.00 |
| Sep 30, 2022 | -1.84 Mn |
| Jun 30, 2022 | -1.87 Mn |
| Mar 31, 2022 | 4.42 Mn |
| Dec 31, 2021 | 1.31 Mn |
| Sep 30, 2021 | 2.53 Mn |
| Jun 30, 2021 | 1.75 Mn |
| Mar 31, 2021 | 1.16 Mn |
| Dec 31, 2020 | 2.40 Mn |
| Sep 30, 2020 | 1.77 Mn |
| Jun 30, 2020 | 1.14 Mn |
| Mar 31, 2020 | 879,000.00 |
| Dec 31, 2019 | 1.39 Mn |
| Sep 30, 2019 | -89.16 Mn |
| Dec 31, 2010 | -267,000.00 |
| Sep 30, 2010 | 240,000.00 |